These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 17146439)

  • 1. PML4 induces differentiation by Myc destabilization.
    Buschbeck M; Uribesalgo I; Ledl A; Gutierrez A; Minucci S; Muller S; Di Croce L
    Oncogene; 2007 May; 26(23):3415-22. PubMed ID: 17146439
    [TBL] [Abstract][Full Text] [Related]  

  • 2. PML4 facilitates erythroid differentiation by enhancing the transcriptional activity of GATA-1.
    Wu J; Zhou LQ; Yu W; Zhao ZG; Xie XM; Wang WT; Xiong J; Li M; Xue Z; Wang X; Zhang P; Mao BB; Hao DL; Lv X; Liu DP
    Blood; 2014 Jan; 123(2):261-70. PubMed ID: 24255919
    [TBL] [Abstract][Full Text] [Related]  

  • 3. PML interacts with Myc, and Myc target gene expression is altered in PML-null fibroblasts.
    Cairo S; De Falco F; Pizzo M; Salomoni P; Pandolfi PP; Meroni G
    Oncogene; 2005 Mar; 24(13):2195-203. PubMed ID: 15735755
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Effect of PML(NLS-) gene mediated by recobinant adenovirus vector on emodin-induced apoptosis of HL-60 cells].
    Gao YM; Liu BZ; Zhang X; Hu XX; Zhong L
    Sichuan Da Xue Xue Bao Yi Xue Ban; 2013 Sep; 44(5):703-7. PubMed ID: 24325094
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Promyelocytic leukemia-nuclear body formation is an early event leading to retinoic acid-induced differentiation of neuroblastoma cells.
    Delaune A; Corbière C; Benjelloun FD; Legrand E; Vannier JP; Ripoll C; Vasse M
    J Neurochem; 2008 Jan; 104(1):89-99. PubMed ID: 17986232
    [TBL] [Abstract][Full Text] [Related]  

  • 6. PML-retinoic acid receptor alpha inhibits PML IV enhancement of PU.1-induced C/EBPepsilon expression in myeloid differentiation.
    Yoshida H; Ichikawa H; Tagata Y; Katsumoto T; Ohnishi K; Akao Y; Naoe T; Pandolfi PP; Kitabayashi I
    Mol Cell Biol; 2007 Aug; 27(16):5819-34. PubMed ID: 17562868
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Promyelocytic Leukemia Protein Isoform II Promotes Transcription Factor Recruitment To Activate Interferon Beta and Interferon-Responsive Gene Expression.
    Chen Y; Wright J; Meng X; Leppard KN
    Mol Cell Biol; 2015 May; 35(10):1660-72. PubMed ID: 25733689
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A RA-dependent, tumour-growth suppressive transcription complex is the target of the PML-RARalpha and T18 oncoproteins.
    Zhong S; Delva L; Rachez C; Cenciarelli C; Gandini D; Zhang H; Kalantry S; Freedman LP; Pandolfi PP
    Nat Genet; 1999 Nov; 23(3):287-95. PubMed ID: 10610177
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A CK2-dependent mechanism for degradation of the PML tumor suppressor.
    Scaglioni PP; Yung TM; Cai LF; Erdjument-Bromage H; Kaufman AJ; Singh B; Teruya-Feldstein J; Tempst P; Pandolfi PP
    Cell; 2006 Jul; 126(2):269-83. PubMed ID: 16873060
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Physical and functional link of the leukemia-associated factors AML1 and PML.
    Nguyen LA; Pandolfi PP; Aikawa Y; Tagata Y; Ohki M; Kitabayashi I
    Blood; 2005 Jan; 105(1):292-300. PubMed ID: 15331439
    [TBL] [Abstract][Full Text] [Related]  

  • 11. B Cell Linker Protein (BLNK) Is a Selective Target of Repression by PAX5-PML Protein in the Differentiation Block That Leads to the Development of Acute Lymphoblastic Leukemia.
    Imoto N; Hayakawa F; Kurahashi S; Morishita T; Kojima Y; Yasuda T; Sugimoto K; Tsuzuki S; Naoe T; Kiyoi H
    J Biol Chem; 2016 Feb; 291(9):4723-31. PubMed ID: 26703467
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Recruitment of the histone methyltransferase SUV39H1 and its role in the oncogenic properties of the leukemia-associated PML-retinoic acid receptor fusion protein.
    Carbone R; Botrugno OA; Ronzoni S; Insinga A; Di Croce L; Pelicci PG; Minucci S
    Mol Cell Biol; 2006 Feb; 26(4):1288-96. PubMed ID: 16449642
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A nucleolar targeting signal in PML-I addresses PML to nucleolar caps in stressed or senescent cells.
    Condemine W; Takahashi Y; Le Bras M; de Thé H
    J Cell Sci; 2007 Sep; 120(Pt 18):3219-27. PubMed ID: 17878236
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Knocking down PML impairs p53 signaling transduction pathway and suppresses irradiation induced apoptosis in breast carcinoma cell MCF-7.
    Bao-Lei T; Zhu-Zhong M; Yi S; Jun-Jie Q; Yan D; Hua L; Bin L; Guo-Wei Z; Zhi-Xian S
    J Cell Biochem; 2006 Feb; 97(3):561-71. PubMed ID: 16215989
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The translation initiation factor 3 subunit eIF3K interacts with PML and associates with PML nuclear bodies.
    Salsman J; Pinder J; Tse B; Corkery D; Dellaire G
    Exp Cell Res; 2013 Oct; 319(17):2554-65. PubMed ID: 24036361
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Direct transcriptional activation of promyelocytic leukemia protein by IFN regulatory factor 3 induces the p53-dependent growth inhibition of cancer cells.
    Kim TK; Lee JS; Oh SY; Jin X; Choi YJ; Lee TH; Lee Eh; Choi YK; You S; Chung YG; Lee JB; DePinho RA; Chin L; Kim H
    Cancer Res; 2007 Dec; 67(23):11133-40. PubMed ID: 18056437
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Selective activation of NFAT by promyelocytic leukemia protein.
    Lo YH; Wu CC; Shih HM; Lai MZ
    Oncogene; 2008 Jun; 27(27):3821-30. PubMed ID: 18246125
    [TBL] [Abstract][Full Text] [Related]  

  • 18. PML regulates p53 stability by sequestering Mdm2 to the nucleolus.
    Bernardi R; Scaglioni PP; Bergmann S; Horn HF; Vousden KH; Pandolfi PP
    Nat Cell Biol; 2004 Jul; 6(7):665-72. PubMed ID: 15195100
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Arsenic degrades PML or PML-RARalpha through a SUMO-triggered RNF4/ubiquitin-mediated pathway.
    Lallemand-Breitenbach V; Jeanne M; Benhenda S; Nasr R; Lei M; Peres L; Zhou J; Zhu J; Raught B; de Thé H
    Nat Cell Biol; 2008 May; 10(5):547-55. PubMed ID: 18408733
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tyrosine kinase inhibitor, methyl 2,5-dihydromethylcinnimate, induces PML nuclear body formation and apoptosis in tumor cells.
    Komura N; Asakawa M; Umezawa K; Segawa K
    Exp Cell Res; 2007 Aug; 313(13):2753-65. PubMed ID: 17585903
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.